Tolemy bio is enabling the future of cell and gene therapy with precision-designed custom media solutions. Using artificial intelligence, machine learning and data-driven insights, we design and manufacture cell culture media tailored uniquely for a product or process to enhance specific therapy production and accelerate r&d timelines. From discovery to clinical development, we’re here to help you enhance cell growth, improve yields, and drive better outcomes for next-generation therapies. We are currently working with immune cell therapies (car-t, til and car-nk), stem cell therapies (msc, hsc and ipscs) and gene therapy (aav and lvv). Get in touch with us at info@tolemy.bio if you’re interested to learn more.